Libya has achieved something truly remarkable: the World Health Organization (WHO) has officially declared the elimination of trachoma as a public health problem in the country. But here's where it gets even more impressive: this milestone was reached despite years of political turmoil and humanitarian crises that strained healthcare services, displaced communities, and put immense pressure on water and sanitation systems. So, how did they do it? And what does this mean for the rest of the world?
On February 18, the WHO announced that Libya has become the 28th country globally—and the eighth in the eastern Mediterranean region—to eliminate trachoma, a contagious bacterial infection that has plagued the country for over a century. And this is the part most people miss: the journey to this achievement involved rigorous surveys, targeted surgical campaigns, and a comprehensive national program that integrated surveillance, expanded healthcare services, and capacity-building for health workers, all in collaboration with local and international partners.
In 2022, surveys across six southern districts revealed that the prevalence of active trachoma and trichiasis—a painful condition where eyelashes turn inward, potentially leading to blindness—had fallen below WHO elimination thresholds. The exception was Wadi Al Hayaa/Ghat, where a surgical campaign was swiftly launched to address remaining cases. By 2025, a follow-up survey confirmed that even trichiasis had dropped below the threshold, solidifying Libya's success.
Here’s where it gets controversial: While Libya’s achievement is undoubtedly a triumph, it raises questions about why other countries facing similar challenges haven’t made the same progress. Is it a matter of resources, political will, or something else entirely? Let’s discuss in the comments.
Trachoma, caused by the bacterium Chlamydia trachomatis, spreads through contact with eye discharge from infected individuals, often via hands, clothing, or flies. Repeated infections can lead to scarring of the inner eyelid and trichiasis, which, if untreated, can cause irreversible blindness. In Libya, the disease was particularly rampant in the south during the 20th century, but control efforts beginning in the 1970s and 1980s led to a significant decline in transmission.
Libya’s success story isn’t just about eliminating a disease—it’s a testament to resilience, innovation, and collaboration. But here’s a thought-provoking question: Can this model be replicated in other regions grappling with political instability and limited resources? Or is Libya’s achievement a unique case? Share your thoughts below and let’s keep the conversation going.
